Barinthus Biotherapeutics plc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Barinthus Biotherapeutics plc. Return On Equity for the quarter ending September 30, 2024 was -34.3 %, a 1.35% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Return On Equity for 2023 was -35.2 %, a 1739% decline from 2022.
  • Barinthus Biotherapeutics plc. annual Return On Equity for 2022 was 2.15 %.
  • Barinthus Biotherapeutics plc. annual Return On Equity for 2021 was -29.4 %, a 150% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -34.3 +0.47 +1.35% Jul 1, 2024 Sep 30, 2024
Q2 2024 -35.9 -12.5 -53.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -36.6 -30.3 -479% Jan 1, 2024 Mar 31, 2024
Q4 2023 -35.2 -37.3 -1739% Oct 1, 2023 Dec 31, 2023
Q3 2023 -34.7 -39.3 -864% Jul 1, 2023 Sep 30, 2023
Q2 2023 -23.4 -22.9 -4150% Apr 1, 2023 Jun 30, 2023
Q1 2023 -6.33 +6.9 +52.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 2.15 +31.5 Oct 1, 2022 Dec 31, 2022
Q3 2022 4.55 +50.5 Jul 1, 2022 Sep 30, 2022
Q2 2022 -0.55 +126 +99.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -13.2 -92.1 -117% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29.4 -88 -150% Oct 1, 2021 Dec 31, 2021
Q3 2021 -45.9 Jul 1, 2021 Sep 30, 2021
Q2 2021 -126 Apr 1, 2021 Jun 30, 2021
Q1 2021 78.9 Jan 1, 2021 Mar 31, 2021
Q4 2020 58.6 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.